For example, ODAM was hypermethyled in 24.27% of the 103 stage I-II CRC patients and these patients had significantly shorter OS time (log-rank test, p = 0.0009) than the other patients without ODAM hypermethylation (Figure 2). This evidence concerns the gene ODAM and colorectal carcinoma.